The Baker Hughes transaction has been approved by Chart shareholders, and the waiting period under the Hart-Scott-Rodino ...
TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today ...
Citigroup posts strong Q3 results with 9% revenue growth, improved profitability, and attractive valuation. Read an analysis of C stock here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback